ProShare Advisors LLC - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 90 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2023$30,079
-10.2%
17,488
+1.9%
0.00%
Q2 2023$33,477
-46.0%
17,168
+14.1%
0.00%
Q1 2022$62,000
-74.5%
15,041
-20.5%
0.00%
Q4 2021$243,000
+153.1%
18,912
+80.5%
0.00%
Q2 2021$96,000
-4.0%
10,476
-5.8%
0.00%
Q4 2019$100,00011,1210.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,561,150$6,125,1783.26%
Redmile Group, LLC 8,509,126$14,635,6970.70%
Avidity Partners Management LP 2,733,800$4,702,1360.19%
Frazier Life Sciences Management, L.P. 1,430,878$2,461,1100.16%
Artia Global Partners LP 95,170$163,6920.07%
Worth Venture Partners, LLC 43,772$75,2880.04%
SkyOak Wealth, LLC 60,875$104,7050.03%
Point72 Asset Management, L.P. 5,924,867$10,190,7710.03%
CORNERCAP INVESTMENT COUNSEL INC 76,811$132,1150.02%
Houlihan Financial Resource Group, Ltd. 20,000$380.02%
View complete list of GRITSTONE ONCOLOGY INC shareholders